Invited Speaker: John Vardakis, Co-Founder & CSO at Science Card

May 23, 2024

We are thrilled to invite John Vardakis to speak at our EPSRC DRIVE-Health CDT's summer symposium next month. John joins us from Science Card to talk about "Exploring the Frontier: The future of GenAI Investments and Collaborations in Industry and Academia."

John Vardakis, PhD, has a diverse work experience, primarily in the field of scientific research. John is currently serving as the Head of Science Card Investment Group at Science Card, where they are involved in innovative banking. Previously, they worked as a Research Scientist at the University of Glasgow, where they focused on simulation-driven microelectromechanical systems design. John also worked as a Research Scientist at INSERM, investigating tumor mechanics and vascular fractality quantification. At the Center for Computational Imaging & Simulation Technologies in Biomedicine (CISTIB), they conducted research in cardiovascular and cerebrovascular biomechanics. Their work at UCL involved computational modeling of dementia and image-guided neurosurgery for epilepsy. John completed their DPhil in Biomedical Engineering at the University of Oxford, where their research focused on fluid transport in the brain. John also gained experience in the fields of vascular diagnosis and market research at the University of Heidelberg and P2i, respectively. Additionally, they worked as a Mechanical Engineer at Enactus and completed a placement at King's College London's Centre for Robotics Research.


John Vardakis, PhD has a strong educational background in engineering and innovation. John obtained their Bachelor of Engineering (BEng) degree in Mechanical Engineering from King's College London in the years 2005 to 2008. John then pursued further education at the University of Oxford, where they completed the Centre for Doctoral Training in Healthcare Innovation from 2009 to 2010. Following this, they earned a Doctor of Philosophy (PhD) degree in Biomedical/Medical Engineering from the University of Oxford from 2010 to 2014. During their time at Oxford, they also pursued a diploma in Strategy & Innovation (Science Innovation Plus programme) from Saïd Business School, University of Oxford, from 2011 to 2012.


In addition to their academic degrees, John Vardakis has obtained additional certifications. In December 2010, they received a Mathwork Training Certificate for completing the "Deploying MATLAB Based Applications - .NET Edition" course. John also obtained another Mathwork Training Certificate in December 2010 for completing the "MATLAB Programming Techniques" course.


Registration is required, please email drivecdt@kcl.ac.uk for further event details.


Our annual Symposium is a one-day face-to-face event for all DRIVE-Health students, academic supervisors, stakeholders and partners.  Our aim is to discuss translating scientific and technological innovations in AI and data science, from research to clinical practice and commercial enterprise.


The symposium will feature keynote talks, panel discussions, and poster presentations showcasing cutting-edge research and successful case studies. We will also celebrate our coming together with networking drinks at the end of the symposium.


The EPSRC DRIVE-Health Centre for Doctoral Training is training the next generation of PhD health data scientists to become the innovation leaders of tomorrow. Our students work within an active NHS environment, and develop new models of data-driven care, whilst leveraging significant recent investment and infrastructure in Health Data Research within the UK.


By registering for this event, you give consent to provide your name, e-mail address and registration information with King's College London for the purposes of managing the EPSRC DRIVE-Health CDT's Summer Symposium. Your personal data will be managed by those organisations and by Eventbrite according to their published privacy policies.



Share

September 2, 2025
We're pleased to announce that DRIVE-Health PhD student, Dr Hugh Logan-Ellis - a Diabetes and Endocrinology Registrar at King's and ex-Research Fellow in the Department of Medicine at Dalhousie University - will deliver our September Seminar Series. In his talk “Extracting Clinical Value from EHR Data: Challenges, Pitfalls, and Practical Lessons" , In his talk, Hugh will share what clinicians have taught him about the reality of working with Electronic Health Record data and what they genuinely need from #AI tools, rather than what researchers might think they should want. Hugh has learned that making the most clinically useful tool could matter more than theoretical perfection. He'll discuss some principles he's gathered to help create AI solutions that fit seamlessly into clinical workflows, which he hopes might help others bridge the gap between academic research and genuine patient benefit. Using his PhD research on creating a single unit of health from #EHR data as a central example, Hugh will explore broader challenges: the messiness of real-world clinical data, the proliferation of unused risk scores, and why so many promising algorithms never make it past publication. These insights aim to help researchers develop tools that won't just die in papers, but have a real chance of improving clinical care. Seminar Series Event: " Extracting Clinical Value from EHR Data: Challenges, Pitfalls, and Practical Lessons" Date and Time: Thursday 25 September 2025, 12:00 – 13.00 hrs (BST) Location: The Judy Dunn Room, SGDP Building, Denmark Hill Campus, London, SE5 8AF Attendance: Mandatory for all DRIVE-Health students, therefore please accept the calendar invitation. Registration: Alumni and wider King's College London research community all welcome - please email drive-health-cdt@kcl.ac.uk to let us know if you would like to attend. Abstract: Picture the scene: It's Saturday morning, you're the senior resident doctor on call in a busy hospital, and you have a 40-page list of patients due for review. Half of your junior colleagues have called in sick, and you know you can't possibly see everyone. How do you decide who needs to be seen most urgently? The information to make these decisions is in the electronic health records, but accessing it quickly means opening each patient's chart individually. My PhD tries to tackle this problem: could we use an algorithm to compress scattered clinical data into a single, practical number? This question has led me on an interesting journey. I've spoken with clinicians from around the world about how they decide who is "sickest," discovering a surprising variety of terms for essentially the same idea and realising we might need more than one measure. My research has taken me to Canada to collaborate with Professor Kenneth Rockwood OC, whose groundbreaking work on frailty measurement has significantly shaped clinical practice worldwide. Working alongside him has given me valuable insights into why some academic ideas successfully transform patient care, while others remain confined to journals. As I explored increasingly sophisticated approaches to measure sickness, from simple laboratory-based indices to complex machine learning models, I stumbled across a key insight. Supervised machine learning can hindered by retrospective health data because when sick patients are successfully treated, they don’t have poor outcomes. This isn't just a quirky finding relevant to my PhD; it has broader implications for using a supervised paradigm on retrospective data whenever effective treatments are already in place. Bio Hugh is a resident medical doctor specialising in Internal Medicine and Diabetes and Endocrinology, working on his PhD at King's College London. His research focuses on measuring patient health status using electronic health records, drawing on his experience working across various healthcare settings in the UK and internationally.
April 9, 2025
We’re pleased to announce that Dr Petroula Laiou from King's College London , will deliver our May Seminar Series with her talk, "Bridging the Gap: Turning Academic Research into Clinical Innovation " . Petroula will share her journey of translating cutting-edge academic research into a mission-driven MedTech company. The spinout is pioneering a novel approach to forecasting and preventing seizures in people with drug-resistant epilepsy - an innovation rooted in years of interdisciplinary work at the intersection of clinical neuroscience, signal processing, and artificial intelligence. Dr. Laiou will take the audience through the full translational pathway: from identifying an unmet clinical need, designing and analysing first-in-human studies, and developing a seizure prediction algorithm, to securing translational funding, navigating the intellectual property landscape, and filing an international patent (PCT/GB2024/052456). She will reflect on key lessons learned during her time in the King’s MedTech Accelerator Programme - where the team won the Best Innovation award - and share insights on building bridges between academia and industry, shaping a commercialization strategy, and transitioning from researcher to entrepreneur. The talk will also highlight the challenges and rewards of launching a spinout in the healthcare sector and offer practical advice for PhD students and early-career researchers considering the entrepreneurial route. Seminar Series Event: "Bridging the Gap: Turning Academic Research into Clinical Innovation" Date and Time: Wednesday 7 May 2025, 15:00 – 16.00 hrs (BST) Location: The Lorna Wing Room, SGDP Building, Denmark Hill Campus, London, SE5 8AF Attendance: Mandatory for all DRIVE-Health students, therefore please accept the calendar invitation. Registration: Alumni and wider King's College London research community all welcome - please email drive-health-cdt@kcl.ac.uk to let us know if you would like to attend. Dr. Petroula Laiou is a Research Fellow in Predictive Modelling and Clinical Neuroscience at King’s College London. With a background in mathematics, computational physics, and a PhD in signal analysis, her research bridges computer science, neuroscience, and machine learning. Her work focuses on developing predictive models and digital biomarkers for neurological and psychiatric disorders, including epilepsy and depression. Dr. Laiou led the development of a novel seizure forecasting algorithm using intracranial EEG and cortical responses to electrical stimulation—research that led to the filing of an international patent (PCT/GB2024/052456). She is the recipient of multiple research grants, including an MRC award as Principal Investigator, and her translational work was recognised by the King’s MedTech Accelerator Programme, where her team won the Best Innovation award. She has authored over 40 peer-reviewed publications, presented at major international conferences, and actively contributes to interdisciplinary collaborations across academia, hospitals, and industry.